Dana Lueck-Mammen
Lawyers
Filters
NGM Biopharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Weyerhaeuser $750 million notes offering
The investment-grade notes are due 2026
HilleVax $200 million IPO
The shares are listed on the Nasdaq Global Select Market
Credo Technology Group $200 million IPO
We advised Credo Technology on its IPO and Nasdaq listing
NVIDIA $5 billion senior notes offering
We advised the joint book-running managers on an investment-grade debt offering
Globe Life $325 million junior subordinated debt offering
We advised the underwriters on the SEC-registered offering
Connect Biopharma $219.9 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Illumina $1 billion notes offering
We advised the underwriters on the investment-grade debt offering
Enphase Energy $1.15 billion green convertible senior notes offering
We advised the initial purchasers on the Rule 144A offering
Sunrun $400 million convertible senior notes offering
We advised the initial purchasers on the Rule 144A offering